MustGrow Biologics Corp. (MGROF) Comparison with companies in other sectors?

MustGrow Biologics Corp. has a share price of 51.64M. You can analyze MustGrow Biologics Corp. (MGROF) competitors across different market sectors through stock heatmaps.

What are MGROF's NET and operating margins?

MustGrow Biologics Corp. (MGROF) operating margin is around -12.35, and net profit margin is approximately -12.28 as of the latest reports.

In what way does MGROF's earnings per share (EPS) trend reflect its financial momentum?

MustGrow Biologics Corp. (MGROF) EPS is -0.07 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for MustGrow Biologics Corp. is -8.29, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for MustGrow Biologics Corp.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for MustGrow Biologics Corp. like P/E which is -8.44, P/B which is 19.03, and PEG which is 0.003. Compare them with sector averages to evaluate if the stock is priced fairly.

MustGrow Biologics Corp.

MGROF•PNK

Basic Materials

Agricultural Inputs

$0.58

$0.00(0.00%)

MustGrow Biologics Corp. (MGROF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.07

P/E Ratio

-8.29

ROE

-1.40%

Net Margin

-12.28%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$29.95M

Shares OutstandingTotal number of shares issued

$51.64M

Book Value/ShareNet worth per share

$0.04

Revenue/ShareAnnual revenue per share

$0.008

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.07

Net MarginNet income as percentage of revenue

-1228.27%

Operating MarginOperating income as percentage of revenue

-1234.69%

ROEReturn on shareholders' equity

-139.88%

ROAReturn on total assets

-90.26%

ROCEReturn on capital employed

-195.04%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.07

Cash/ShareCash and equivalents per share

$0.06

FCF YieldFree cash flow as percentage of market cap

-8.67%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for MGROFFinancial Ratios Analysis details for MGROF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MGROFSector Benchmarking details for MGROF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for MustGrow Biologics Corp. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of MustGrow Biologics Corp.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account MustGrow Biologics Corp.'s unique business strengths and challenges.

Key Financial Metrics for MustGrow Biologics Corp.

For MustGrow Biologics Corp., essential financial indicators include EPS -0.07, PE -8.29, and ROE -1.40. These key ratios reveal insights into MustGrow Biologics Corp.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare MustGrow Biologics Corp. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of MustGrow Biologics Corp.

Metrics like Net Margin -1228.27% and ROA -90.26% shed light on how well MustGrow Biologics Corp. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether MustGrow Biologics Corp. can sustain its operations and continue growing in the future.

Valuation and Market Position of MustGrow Biologics Corp.

Using ratios such as P/B Ratio 19.03 and PEG Ratio 0.003, investors can assess whether MustGrow Biologics Corp. is appropriately valued based on its financials and growth potential. These figures, combined with MustGrow Biologics Corp.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for MustGrow Biologics Corp.

Financial health indicators, such as Debt/Equity Ratio 0.24 and Cash Flow $-0.07, provide a snapshot of MustGrow Biologics Corp.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like MustGrow Biologics Corp., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for MustGrow Biologics Corp.

Investing in MustGrow Biologics Corp. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at MustGrow Biologics Corp. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;